GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Paul Hartmann AG (FRA:PHH2) » Definitions » Valuation Rank

Paul Hartmann AG (FRA:PHH2) Valuation Rank


View and export this data going back to . Start your Free Trial

What is Paul Hartmann AG Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Paul Hartmann AG Valuation Rank Related Terms

Thank you for viewing the detailed overview of Paul Hartmann AG's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Paul Hartmann AG (FRA:PHH2) Business Description

Traded in Other Exchanges
Address
Paul-Hartmann-Strasse 12, Heidenheim, DEU, 89522
Paul Hartmann AG engages in the production of medical and hygiene products. It operates through Wound Management, Incontinence Management and Infection Management and other segments. The Wound segment comprises wound dressing and treatment, compression therapy, first aid, immobilization, and diagnostics. The Incontinence segment provides incontinence hygiene, patient care, and medical skin care. The Infection segment consists of custom procedure trays, surgical draping systems, disposable surgical instruments, and disinfectants. The Other activities include activities in cotton-wool products, medical consumer goods and pharmaceutical products and others. All the activities are functioned through the region of US and derive revenue through the sale of medical and hygiene products.
Executives
Eduard Schleicher Supervisory Board
Britta Fünfstück Board of Directors